Pathstone Family Office, LLC Johnson & Johnson Transaction History

Pathstone Family Office, LLC

$15.6 Billion
Q3 2023

A detailed history of Pathstone Family Office, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Pathstone Family Office, LLC holds 231,738 shares of JNJ stock, worth $33.9 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

231,738

Previous 86,069 169.25%

Holding current value

$33.9 Million

Previous $14.2 Million 153.36%

% of portfolio

0.23%

Previous 0.22%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$155.75 - $174.48 $22.7 Million - $25.4 Million	145,669 Added 169.25%	231,738 $36.1 Million
Q2 2023 Jan 12, 2024	SELL	$154.35 - $166.11 $22.5 Million - $24.2 Million	-145,667 Reduced 62.86%	86,071 $14.2 Million
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $204,205 - $219,763	1,323 Added 1.56%	86,069 $14.2 Million
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $6.87 Million - $8.2 Million	-45,509 Reduced 34.94%	84,746 $13.1 Million
Q4 2022 Oct 23, 2023	BUY	$160.2 - $179.79 $8.37 Million - $9.39 Million	52,221 Added 66.92%	130,255 $23 Million

Q4 2022 Feb 13, 2023	BUY	$160.2 - $179.79 $1.34 Million - $1.5 Million	8,360 Added 6.86%	130,255 $23 Million
Q3 2022 Oct 23, 2023	BUY	$161.33 - $179.52 $5.3 Million - $5.9 Million	32,877 Added 72.81%	78,034 $12.7 Million
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $5.2 Million - $5.79 Million	32,238 Added 35.96%	121,895 $20.1 Million
Q2 2022 Oct 23, 2023	SELL	$168.19 - $186.01 $6.88 Million - $7.61 Million	-40,912 Reduced 47.53%	45,157 $8.02 Million
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $11.2 Million - $12.4 Million	66,501 Added 287.19%	89,657 $15.9 Million
Q1 2022 May 16, 2022	BUY	$158.14 - $179.59 $13,441 - $15,265	85 Added 0.37%	23,156 $4.29 Million
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $225,006 - $249,653	-1,443 Reduced 5.89%	23,071 $3.95 Million
Q3 2021 Nov 16, 2021	SELL	$161.5 - $179.47 $64,923 - $72,146	-402 Reduced 1.61%	24,514 $3.96 Million
Q2 2021 Aug 31, 2021	BUY	$159.48 - $171.07 $701,074 - $752,023	4,396 Added 21.42%	24,916 $4.11 Million
Q1 2021 May 14, 2021	BUY	$153.07 - $170.48 $1.65 Million - $1.84 Million	10,808 Added 111.29%	20,520 $3.37 Million
Q4 2020 Feb 16, 2021	BUY	$137.11 - $157.38 $748,620 - $859,294	5,460 Added 128.41%	9,712 $1.53 Million
Q3 2020 Nov 12, 2020	BUY	$140.38 - $153.83 $15,862 - $17,382	113 Added 2.73%	4,252 $632,000
Q2 2020 Aug 14, 2020	SELL	$128.81 - $155.51 $125,847 - $151,933	-977 Reduced 19.1%	4,139 $583,000
Q1 2020 Jun 11, 2020	BUY	$111.14 - $153.99 $553,588 - $767,024	4,981 Added 3689.63%	5,116 $673,000
Q1 2020 May 07, 2020	SELL	$111.14 - $153.99 $415,552 - $575,768	-3,739 Reduced 96.52%	135 $17.7 Million
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $45,772 - $52,571	-359 Reduced 8.48%	3,874 $5.65 Million
Q3 2019 Nov 13, 2019	SELL	$126.95 - $142.14 $875,066 - $979,771	-6,893 Reduced 61.95%	4,233 $548,000
Q2 2019 Aug 14, 2019	BUY	$131.15 - $144.24 $52,197 - $57,407	398 Added 3.71%	11,126 $1.55 Million
Q1 2019 May 14, 2019	BUY	$125.72 - $139.79 $651,858 - $724,811	5,185 Added 93.54%	10,728 $1.5 Million
Q4 2018 Feb 14, 2019	BUY	$122.84 - $147.84 $259,806 - $312,681	2,115 Added 61.7%	5,543 $715,000
Q3 2018 Nov 09, 2018	SELL	$121.58 - $142.88 $18,237 - $21,432	-150 Reduced 4.19%	3,428 $473,000
Q2 2018 Aug 10, 2018	SELL	$119.4 - $131.76 $31,402 - $34,652	-263 Reduced 6.85%	3,578 $434,000
Q1 2018 May 15, 2018	BUY	$125.1 - $148.14 $7,631 - $9,036	61 Added 1.61%	3,841 $492,000
Q4 2017 Feb 12, 2018	SELL	$131.22 - $143.62 $1,180 - $1,292	-9 Reduced 0.24%	3,780 $529,000
Q3 2017 Nov 14, 2017	SELL	$129.47 - $135.38 $440,198 - $460,292	-3,400 Reduced 47.29%	3,789 $492,000
Q2 2017 Aug 16, 2017	BUY	N/A	7,189	7,189 $951,000

Others Institutions Holding JNJ

# of Institutions

4,146

Shares Held

1.64B

Call Options Held

15.1M

Put Options Held

12.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $383B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.

Account

Pathstone Family Office, LLC Johnson & Johnson Transaction History